Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal <sup>1</sup>H and <sup>129</sup>Xe Lung MRI in Patients With Post-COVID Residual Lung Abnormalities.

Journal of magnetic resonance imaging : JMRI·2026
Same author

CGRP-targeted migraine treatment and early pathophysiology in experimental subarachnoid hemorrhage.

The journal of headache and pain·2026
Same author

Nociceptive action of calcitonin gene-related peptide in the trigeminovascular system.

Nature reviews. Neurology·2026
Same author

Hypothalamic and sex-related hormones in migraine.

The journal of headache and pain·2026
Same author

Understanding RAMP1's role in hormonal migraine may improve CGRP-targeted therapies.

Expert review of clinical pharmacology·2026
Same author

Expression of melatonin receptors in trigeminal and sphenopalatine ganglia: potential targets for primary headache disorders.

The journal of headache and pain·2025

Related Experiment Video

Updated: Jul 9, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

PKC and MAPK signalling pathways regulate vascular endothelin receptor expression.

David Nilsson1, Angelica Wackenfors, Lotta Gustafsson

  • 1Department of Medicine, Lund University Hospital, Lund, Sweden.

European Journal of Pharmacology
|November 23, 2007
PubMed
Summary
This summary is machine-generated.

Protein kinase C (PKC) and mitogen-activated kinases (MAPK) regulate vascular endothelin receptors in porcine coronary arteries. Inhibiting these pathways may offer therapeutic targets for cardiovascular disease.

More Related Videos

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-&#946; Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Related Experiment Videos

Last Updated: Jul 9, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-&#946; Signaling
07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Area of Science:

  • Cardiovascular Biology
  • Molecular Pharmacology
  • Cell Signaling

Background:

  • Vascular endothelin receptors (ET(A) and ET(B)) are implicated in cardiovascular disease pathogenesis.
  • Arterial culture models exhibit receptor alterations, making them suitable for studying endothelin receptor regulation.

Purpose of the Study:

  • To investigate the involvement of protein kinase C (PKC) and mitogen-activated kinases (MAPK) in regulating endothelin receptors in porcine coronary arteries.
  • To determine if inhibiting PKC and MAPK can modulate endothelin receptor expression and function in cultured arteries.

Main Methods:

  • Porcine coronary arteries were cultured for 24 hours and analyzed using in vitro pharmacology, real-time PCR, and immunofluorescence.
  • Receptor function was assessed using sarafotoxin 6c and endothelin-1.
  • PKC and MAPK involvement was studied using specific inhibitors (bisindolylmaleimide I, Ro-32-0432, PD98059, SP600125, SB203580).

Main Results:

  • Organ culture increased ET(A) and ET(B) receptor protein expression and ET(B) receptor mRNA levels.
  • PKC inhibitors blocked these culture-induced changes.
  • MAPK inhibitors targeting ERK1/2 and JNK, but not p38 MAPK, also inhibited the receptor alterations.

Conclusions:

  • PKC and MAPK signaling pathways are involved in the regulation of endothelin receptor expression in porcine coronary arteries.
  • Targeting these intracellular pathways presents a potential therapeutic strategy to prevent vascular endothelin receptor dysregulation in cardiovascular disease.